User profiles for Gerco den Hartog
 | Gerco den HartogNational Institute for Public Health and the Environment (RIVM) Verified email at rivm.nl Cited by 2519 |
[HTML][HTML] Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis
LD Butcher, G den Hartog, PB Ernst… - Cellular and molecular …, 2017 - Elsevier
Helicobacter pylori is a gram-negative, microaerophilic bacterium that infects the stomach and
can lead to, among other disorders, the development of gastric cancer. The inability of the …
can lead to, among other disorders, the development of gastric cancer. The inability of the …
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
D Geers, MC Shamier, S Bogers, G den Hartog… - Science …, 2021 - science.org
The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has
raised concern about potential immune escape. Here, we studied humoral and cellular …
raised concern about potential immune escape. Here, we studied humoral and cellular …
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …
…, EF Smit, TJN Hiltermann, G den Hartog… - The Lancet …, 2021 - thelancet.com
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …
infection. Vaccination to prevent COVID-19 is recommended, but data on the …
SARS-CoV-2–specific antibody detection for seroepidemiology: a multiplex analysis approach accounting for accurate seroprevalence
G den Hartog, RM Schepp, M Kuijer… - The Journal of …, 2020 - academic.oup.com
Background The COVID-19 pandemic necessitates better understanding of the kinetics of
antibody production induced by infection with SARS-CoV-2. We aimed to develop a high-…
antibody production induced by infection with SARS-CoV-2. We aimed to develop a high-…
Antibody response in immunocompromised patients with hematologic cancers who received a 3-dose mRNA-1273 vaccination schedule for COVID-19
…, RS Van Binnendijk, G Den Hartog… - JAMA …, 2022 - jamanetwork.com
Importance It has become common practice to offer immunocompromised patients with
hematologic cancers a third COVID-19 vaccination dose, but data substantiating this are scarce. …
hematologic cancers a third COVID-19 vaccination dose, but data substantiating this are scarce. …
Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study
G den Hartog, ERA Vos… - Clinical Infectious …, 2021 - academic.oup.com
Background Assessing the duration of immunity following infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a first priority to gauge the degree of …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a first priority to gauge the degree of …
[HTML][HTML] The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on …
…, D Geers, CH GeurtsvanKessel, G den Hartog… - …, 2022 - journals.lww.com
Background. In kidney patients COVID-19 is associated with severely increased morbidity
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
[HTML][HTML] Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA …
…, R van Binnendijk, G den Hartog… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave
ERA Vos, G den Hartog, RM Schepp… - J epidemiol community …, 2021 - jech.bmj.com
Background We aimed to detect SARS-CoV-2 serum antibodies in the general population of
the Netherlands and identify risk factors for seropositivity amidst the first COVID-19 …
the Netherlands and identify risk factors for seropositivity amidst the first COVID-19 …
[HTML][HTML] Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
B de Gier, AJ Huiberts, CE Hoeve, G den Hartog… - Nature …, 2023 - nature.com
An increasing proportion of the population has acquired immunity through COVID-19 vaccination
and previous SARS-CoV-2 infection, ie, hybrid immunity, possibly affecting the risk of …
and previous SARS-CoV-2 infection, ie, hybrid immunity, possibly affecting the risk of …